Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Janet Storella

Diagnostic Radiology Washington, DC Medical Doctor

NPI 1073503785 CMS profile 564223

1145 19Th St Nw, Suite 205, Washington, DC 20036

Open in the dashboard

General payments

$3,200

18 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Janet Storella of Washington, DC is reported in the CMS Open Payments database as having received $3,200 across 18 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $149 2
2023 General $1,464 5
2022 General $1,314 6
2020 General $104 2
2019 General $169 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Janet Storella
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Janet Storella were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Janet Storella Diagnostic Radiology median Middle half National median
2019 $169 $108 $29–$318 $163
2020 $104 $65 $21–$252 $114
2021 $0 $92 $24–$292 $132
2022 $1,314 $104 $29–$294 $149
2023 $1,464 $110 $29–$337 $160
2024 $149 $113 $30–$356 $164
2025 $0 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Ge Healthcare $2,670 10 payments
  2. Volpara Solutions Inc $220 2 payments
  3. Bard Peripheral Vascular, Inc. $133 3 payments
  4. NeuroLogica Corporation, A Subsidiary of Samsung Electronics $130 1 payment
  5. Delphinus Medical Technologies, Inc. $28 1 payment
  6. Hologic Inc $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Travel and Lodging $2,142 2 payments
  2. Food and Beverage $1,058 16 payments
Products named General payments · program years 2019–2024
  1. Hera W10 $130 1 payment
  2. 3DIMENSIONS $18 1 payment
  3. Clarity $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 94 billing codes

Paid by Medicare

$459,325

Of which drugs: $1,913

Medicare patients

1,982

Average age 74

Services billed

23,992

1,889 women, 93 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 46%
Osteoporosis 27%
Diabetes 24%
Cancer 22%
Ischemic heart disease 16%
Depression 15%
Chronic kidney disease 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadoterate meglumine, 0.1 ml A9575 Office 135 17,195 $1,634
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 32 2,745 $279

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

18 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record